Put Osteonecrosis of the Jaw Risk in Perspective

June 2023

Questions are still popping up about the risk of osteonecrosis of the jaw due to meds.

About 20 years ago, the first cases of med-related osteonecrosis of the jaw were reported after bisphosphonate use.

These patients develop persistent exposed bone...or a fistula down to the bone...in the upper or lower jaw.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Navigate Ongoing COVID-19 Vaccine Changes
Cholesterol Think “Lower Is Better” for LDL in Patients at High CV Risk
Diabetes Individualize Sick Day Management for Diabetes
Dermatology Evaluate the Role of OTC and Rx Options for Poison Ivy
Med Adherence Consider Approaches to Improve Med Adherence
Dermatology Educate About Skin Cancer Detection and Protection
Antiplatelets Tailor DAPT Duration for Patients at High Bleeding Risk
Med Safety Put Osteonecrosis of the Jaw Risk in Perspective
Pediatrics Address the Rise in Childhood Obesity
Fungal Infections Help Manage Candida auris
Cardiology Compare Rate Control Options for Acute Atrial Fibrillation